| Trial ID: | L2787 |
| Source ID: | NCT06611904
|
| Associated Drug: |
Dulaglutide
|
| Title: |
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Urine Albumin (UAlb)|Glycocalyx|Arterial Stiffness
|
| Interventions: |
DRUG: Dulaglutide|DRUG: DPP-4 Inhibitors
|
| Outcome Measures: |
Primary: UACR, UACR change after 4 and 12 months of treatment, 4 and 12 months|PWV, PWV change after 4 and 12 months of treatment, 4 and 12 months|PBR, PBR change after 4 and 12 months of treatment, 4 and 12 months|GLS, GLS change after 4 and 12 months of ttreatment, 4 and 12 months |
|
| Sponsor/Collaborators: |
Sponsor: Attikon Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2018-02-01
|
| Completion Date: |
2024-12-15
|
| Results First Posted: |
|
| Last Update Posted: |
2024-09-25
|
| Locations: |
Attikon University General Hospital, Chaidari, Attica, 12462, Greece
|
| URL: |
https://clinicaltrials.gov/show/NCT06611904
|
